Amorphous kinase inhibitor formulations and methods of use thereof | Patent Number 11801237

US 11801237 B2
Application Number18314348
Publication NumberUS 20230270728 A1
Pendency5 months, 25 days
Filled DateMay 9, 2023
Priority DateDec 30, 2019
Publication DateAug 31, 2023
Expiration DateDec 29, 2039
Inventor/ApplicantsScott Bone
Michael D. Kaufman
Corey Bloom
Fred Jordan
ExaminesTRAN, SUSAN T
Art Unit1615
Technology Center1600
Assignments
Bend Research Inc.
Current
Deciphera Pharmaceuticals Llc
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.